The tweet was deleted by the author.
But we saved everything 🙂.
Danny Naz highlights the strong performance of P shares, reporting a 147 percent increase with three months remaining in the period.
Additionally, he notes a 29 percent gain in the share price. Further details were not provided in the tweet.
Naz has previously highlighted new bullish ratings on high beta biotech stocks including LYEL, APGE, and ARWR from major firms such as Baird and JPM in recent coverage. In a separate note, he outlined essential trading habits focused on process discipline and patience, as detailed in his review of successful strategies. His updates offer regular insights into individual share movements and trader approaches.